【其他高分选 072】

BC

PMID: 39397336

IF:10

Glutathione-Depleted Photodynamic Nanoadjuvant for Triggering Nonferrous Ferroptosis to Amplify Radiotherapy of Breast Cancer

PMID:39418072

IF:14.3

Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets

PMID:39415210

IF:27.7

Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR

PMID:39414946

IF:23.5

Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations

PMID:39413849

IF:10.5

Microneedles integrated with atorvastatin-loaded pumpkisomes for breast cancer therapy: A localized delivery approach

PMID:39431333

IF:14.3

Advancing Anticancer Drug Discovery: Leveraging Metabolomics and Machine Learning for Mode of Action Prediction by Pattern Recognition

PMID:39436292

IF:12.1

Time-Dependent Diffusion MRI Helps Predict Molecular Subtypes and Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer

PMID:39437149

IF:12.5

Distant Metastases of Breast Cancer Resemble Primary Tumors in Cancer Cell Composition but Differ in Immune Cell Phenotypes

CRC

PMID:39417395

IF:20.1

Nine-fold variation of risk of advanced colorectal neoplasms according to smoking and polygenic risk score: Results from a cross-sectional study in a large screening colonoscopy cohort

PMID:39415226

IF:10.6

Photothermal Fe(3)O(4) nanoparticles induced immunogenic ferroptosis for synergistic colorectal cancer therapy

PMID:39414242

IF:11.5

Application of Duty of Candour legislation in post-colonoscopy colorectal cancer: a prospective cohort study

PMID:39413732

IF:11.7

Deep learning model with pathological knowledge for detection of colorectal neuroendocrine tumor

PMID:39419977

IF:40.8

Sequential responsive nano-PROTACs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapy

PMID:39419366

IF:12.1

Ferroptosis and immunosenescence in colorectal cancer

PMID:39425000

IF:13.7

Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing

PMID:39424357

IF:11.5

Prospective randomized trial comparing conventional and underwater endoscopic submucosal dissection for superficial colorectal neoplasms

PMID:39423564

IF:10.7

Semi-supervised ViT knowledge distillation network with style transfer normalization for colorectal liver metastases survival prediction

PMID:39436710

IF:13.3

MOGAT3-Mediated DAG Accumulation Drives Acquired Resistance to Anti-BRAF/EGFR Therapy in BRAFV600E-Mutant Metastatic Colorectal Cancer

PMID:39438165

IF:18.8

Integrated analysis of radiomics, RNA, and clinicopathologic phenotype reveals biological basis of prognostic risk stratification in colorectal cancer

GC

PMID:39414226

IF:11.4

Single-cell transcriptomic profiling uncovers cellular complexity and microenvironment in gastric tumorigenesis associated with Helicobacter pylori

PMID:39415013

IF:50.5

An ancient ecospecies of Helicobacter pylori

PMID:39422533

IF:12.5

Efficacy of ursodeoxycholic acid for bile reflux after distal gastrectomy in patients with gastric cancer: A secondary analysis of the PEGASUS-D randomized clinical trial

PMID:39420158

IF:58.7

Helicobacter pylori, gastric cancer and the screening conundrum

PMID:39433839

IF:81.1

The TOPGEAR trial - is chemoradiotherapy no longer a component of multidisciplinary care for gastric cancer?

PMID:39438124

IF:23

IQGAP3 signalling mediates intratumoral functional heterogeneity to enhance malignant growth

HCC

PMID:39422063

IF:14.3

Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis

PMID: 39423823

IF:14.5

Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinoma

PMID: 39423866

IF:26.8

Hepatocellular Carcinoma Patients as an Ideal Study Population for Immune Checkpoint Inhibitors in Hepatitis B

PMID: 39424235

IF:25.7

GLP-1 Receptor Agonists' Role in Reducing Hepatocellular Carcinoma Risk

PMID: 39431335

IF:15.8

Intracellular Magnetic Hyperthermia Sensitizes Sorafenib to Orthotopic Hepatocellular Carcinoma Via Amplified Ferroptosis

PMID: 39435267

IF:11.6

Combination Assay of Methylated HOXA1 with Tumor Markers Shows High Sensitivity for Detection of Early-Stage Hepatocellular Carcinoma

LC

PMID: 39417737

IF:19.3

Associations of Social Determinants and Community Resilience with Lung Cancer Incidence and Mortality in the US

PMID: 39413736

IF:11.7

Modeling lung adenocarcinoma metastases using patient-derived organoids

PMID: 39413875

IF:56.7

Lung Cancer Research and Treatment: Global Perspectives and Strategic Calls to Action

PMID:39424456

IF:11.4

Targeting ACSLs to modulate ferroptosis and cancer immunity

PMID:39423815

IF:48.8

IL-1 signaling in aging and cancer: An inflammaging feedback loop unveiled

PMID:39431325

IF:13

Rebooting the Adaptive Immune Response in Immunotherapy-Resistant Lung Adenocarcinoma Using a Supramolecular Albumin

PMID:39435643

IF:14.3

Pericytes Modulate Third-Generation Tyrosine Kinase Inhibitor Sensitivity in EGFR-Mutated Lung Cancer Cells Through IL32-beta5-Integrin Paracrine Signaling

PMID:39436294

IF:12.1

Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial

PMID:39437166

IF:12.5

SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma

PMID:39437814

IF:14.8

Association of Intellectual and Developmental Disabilities With Worse Outcomes After Surgical Treatment of Cancer

PMID:39438124